Insiders CASI Pharmaceuticals, Inc.

Equities

CASI

KYG1933S1012

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-20 pm EDT			5-day change	1st Jan Change
3.13 ^USD	-5.15%		+22.03%	-56.28%

May. 15	Sector Update: Health Care Stocks Advance in Afternoon Trading	MT
May. 15	CASI Pharmaceuticals Gets FDA Clearance For Blood Disorder Study	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CASI Pharmaceuticals, Inc. Announces Resignation of Fuqiang Zhang as Chief Commercial Officer	Feb. 12	CI
CASI Pharmaceuticals, Inc. Appoints of Mr. Huang Hai as the Global Chief Commercial Officer	Jan. 30	CI
HBM Holdings Names CFO/Chief Business Officer	22-11-13	MT
OncoSec Medical Appoints George Chi as CFO	22-02-23	MT
CASI Pharmaceuticals, Inc. Appoints Alexander A. Zukiwski as Executive Vice President	21-12-10	CI
Insider Trends: Insider Buy at CASI Pharmaceuticals, Slows 90-Days of Sells	21-03-30	MT
CASI Pharmaceuticals, Inc. Announces Resignation of Weihao Xu as Chief Financial Officer	21-03-25	CI
Casi Pharmaceuticals, Inc. Appoints Weihao Xu Principal Financial and Accounting Officer	20-12-16	CI
CASI Pharmaceuticals, Inc. Appoints Weihao Xu as Chief Financial Officer	20-12-16	CI
Insider Trends: 90-Day Insider Selling Trend at CASI Pharmaceuticals Slowed with Acquisition of Shares	20-11-24	MT
CASI Pharmaceuticals, Inc. Appoints Wei Larry Zhang to Serve as the Interim Principal Financial Officer	20-03-06	CI
CASI Pharmaceuticals, Inc. Announces Retirement of Ken K. Ren from the Board of Directors	19-11-13	CI
CASI Pharmaceuticals, Inc. Names Wei Larry Zhang as President	19-09-11	CI
CASI Pharmaceuticals, Inc. Appoints James Huang to the Board of Directors	19-06-21	CI
CASI Pharmaceuticals, Inc. Announces Executive Changes	19-04-02	CI
CASI Pharmaceuticals, Inc. Announces Appointment of George Chi as Chief Financial Officer	18-09-28	CI
CASI Pharmaceuticals, Inc. Hires Thomas Zhang as General Manager of its Sales & Marketing Team in China	18-05-15	CI
CASI Pharmaceuticals, Inc. Appoints Dr. Wei-Wu He as Executive Chairman	18-02-09	CI
CASI Pharmaceuticals Appoints James E. Goldschmidt as Vice President of Business Development	16-04-18	CI
CASI Pharmaceuticals, Inc. Announces Clinical Advisory Board Appointments	15-07-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders CASI Pharmaceuticals, Inc.

Equities

CASI

KYG1933S1012

Insiders

Filters